Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Alpen Co's Sloan Ratio for the quarter that ended in Mar. 2026 was 0.00%.
As of Mar. 2026, Alpen Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Alpen Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Alpen Co Sloan Ratio % Related Terms
Alpen Co Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Alpen Co's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGO:3028 vs CASY, WSM, ULTA: Sloan Ratio % Comparison
For the Specialty Retail subindustry, Alpen Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpen Co Sloan Ratio % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Alpen Co's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Alpen Co's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Alpen Co's Sloan Ratio for the fiscal year that ended in Jun. 2026 is calculated as
Alpen Co's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 1074 (Jun. 2025 ) + 606 (Sep. 2025 ) + 2150 (Dec. 2025 ) + 855 (Mar. 2026 ) = 円4,685 Mil.
Alpen Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) + 0 (Mar. 2026 ) = 円0 Mil.
Alpen Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) + 0 (Mar. 2026 ) = 円0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpen Co (NGO:3028) has a Sloan Ratio % of 0.00% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Alpen Co and its competitors.
Is Alpen Co's Sloan Ratio % too high?
Alpen Co's current Sloan Ratio % is 0.00%. Overall, Alpen Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Alpen Co's Sloan Ratio % compare to CASY and WSM?
Alpen Co's Sloan Ratio % of 0.00% can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Retail - Cyclical company?
A good Sloan Ratio % depends on the Retail - Cyclical industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Alpen Co and its competitors. Alpen Co's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpen Co stock overvalued right now?
Alpen Co (NGO:3028) has a current Sloan Ratio % of 0.00%. The stock's GF Value™ is 円2,019.34, compared to a current price of 円2,005.00 — trading 0.7% below its estimated fair value. The current Sloan Ratio % is 0.00%. Alpen Co's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Alpen Co (NGO:3028), the current Sloan Ratio % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpen Co (NGO:3028) Overvalued in 2026?
Based on GuruFocus' analysis, Alpen Co stock appears to be undervalued.
The current stock price of 円2,005.00 is trading 0.7% below its estimated GF Value™ of 円2,019.34.
Key valuation signals for NGO:3028:
Sloan Ratio %: 0.00%
GF Value™: 円2,019.34 vs. price of 円2,005.00 (0.7% below fair value)
No single metric tells the full story. See the NGO:3028 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpen Co Ltd is a Japan-based specialty retailer that is primarily engaged in the production and sale of sports products. The company's products consist of sports equipment, apparel, accessories, dietary supplements, and other items. The company operates through three store formats, including Alpen, focusing on products related to winter sports; Golf 5, primarily providing golf-related sports products; Sports Depo, which offers all kinds of sporting goods. The Sports Depo accounts for around half of the company's total revenue. The company runs a nationwide retail network across Japan.
69GF Score
Get the complete analysis for NGO:3028
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGO:3028 has been successfully added to your 
